Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study of Pregabalin in Fibromyalgia

ClinicalTrials.gov ID: NCT00151489

Public ClinicalTrials.gov record NCT00151489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.

Study identification

NCT ID
NCT00151489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,020 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2005 (Type not available)
Primary completion
Not listed
Completion
Jun 2006 (Actual)
Last update posted
Jan 22, 2021

2005 – 2006

United States locations

U.S. sites
109
U.S. states
36
U.S. cities
94
Facility City State ZIP Site status
Pfizer Investigational Site Anniston Alabama 36207 —
Pfizer Investigational Site Birmingham Alabama 35235 —
Pfizer Investigational Site Calera Alabama 35040 —
Pfizer Investigational Site Huntsville Alabama 35801 —
Pfizer Investigational Site Tuscaloosa Alabama 35406 —
Pfizer Investigational Site Phoenix Arizona 85013 —
Pfizer Investigational Site Phoenix Arizona 85023 —
Pfizer Investigational Site Scottsdale Arizona 85251 —
Pfizer Investigational Site Fayetteville Arkansas 72703 —
Pfizer Investigational Site Hot Springs Arkansas 71913 —
Pfizer Investigational Site Anaheim California 92801 —
Pfizer Investigational Site Carmichael California 95608 —
Pfizer Investigational Site Fresno California 93710 —
Pfizer Investigational Site Los Alamitos California 90720 —
Pfizer Investigational Site Northridge California 91324 —
Pfizer Investigational Site Pismo Beach California 93449 —
Pfizer Investigational Site Santa Ana California 92705 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site Whittier California 90601 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Stratford Connecticut 06615 —
Pfizer Investigational Site Newark Delaware 19713 —
Pfizer Investigational Site Washington D.C. District of Columbia 20010 —
Pfizer Investigational Site Chiefland Florida 32680 —
Pfizer Investigational Site Clearwater Florida 33761 —
Pfizer Investigational Site Kissimmee Florida 34741 —
Pfizer Investigational Site Miami Florida 33173 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Palm Harbor Florida 34684 —
Pfizer Investigational Site Palm Springs Florida 33461 —
Pfizer Investigational Site Plantation Florida 33317 —
Pfizer Investigational Site Plantation Florida 33324 —
Pfizer Investigational Site St. Petersburg Florida 33709 —
Pfizer Investigational Site Sunrise Florida 33351 —
Pfizer Investigational Site Tampa Florida 33609 —
Pfizer Investigational Site West Palm Beach Florida 33409 —
Pfizer Investigational Site Atlanta Georgia 30328 —
Pfizer Investigational Site Gurnee Illinois 60031 —
Pfizer Investigational Site Peoria Illinois 61614 —
Pfizer Investigational Site Evansville Indiana 47712 —
Pfizer Investigational Site Evansville Indiana 47714 —
Pfizer Investigational Site Indianapolis Indiana 46254 —
Pfizer Investigational Site Prairie Village Kansas 66206 —
Pfizer Investigational Site Lexington Kentucky 40509 —
Pfizer Investigational Site Lexington Kentucky 40536-0284 —
Pfizer Investigational Site Lexington Kentucky 40536 —
Pfizer Investigational Site Owensboro Kentucky 42303 —
Pfizer Investigational Site Baton Rouge Louisiana 70809 —
Pfizer Investigational Site New Orleans Louisiana 70114 —
Pfizer Investigational Site New Orleans Louisiana 70128 —
Pfizer Investigational Site Springfield Massachusetts 01107 —
Pfizer Investigational Site Worcester Massachusetts 01610 —
Pfizer Investigational Site Kalamazoo Michigan 49009 —
Pfizer Investigational Site Lansing Michigan 48917 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Jackson Mississippi 39202 —
Pfizer Investigational Site Blue Springs Missouri 64014 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Henderson Nevada 89014 —
Pfizer Investigational Site Cherry Hill New Jersey 08002 —
Pfizer Investigational Site Edison New Jersey 08817 —
Pfizer Investigational Site Highland Park New Jersey 08904 —
Pfizer Investigational Site Ridgewood New Jersey 07450 —
Pfizer Investigational Site South Eddison New Jersey 08817 —
Pfizer Investigational Site Albany New York 12205 —
Pfizer Investigational Site Johnson City New York 13790 —
Pfizer Investigational Site Rochester New York 14618 —
Pfizer Investigational Site Smithtown New York 11787-2817 —
Pfizer Investigational Site Charlotte North Carolina 28207 —
Pfizer Investigational Site Charlotte North Carolina 28209 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Raleigh North Carolina 27612 —
Pfizer Investigational Site Salisbury North Carolina 28144 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Cincinnati Ohio 45219 —
Pfizer Investigational Site Columbus Ohio 43212 —
Pfizer Investigational Site Mogadore Ohio 44260 —
Pfizer Investigational Site Toledo Ohio 43623 —
Pfizer Investigational Site Tulsa Oklahoma 74104 —
Pfizer Investigational Site Eugene Oregon 97401 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Bensalem Pennsylvania 19020 —
Pfizer Investigational Site Mechanicsburg Pennsylvania 17055 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15213 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15218 —
Pfizer Investigational Site West Reading Pennsylvania 19611-1124 —
Pfizer Investigational Site Charleston South Carolina 29406 —
Pfizer Investigational Site Greenville South Carolina 29601 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Sioux Falls South Dakota 57105 —
Pfizer Investigational Site Memphis Tennessee 38119 —
Pfizer Investigational Site Nashville Tennessee 37207 —
Pfizer Investigational Site Austin Texas 78705 —
Pfizer Investigational Site Fort Worth Texas 76107 —
Pfizer Investigational Site San Antonio Texas 78217 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Layton Utah 84041 —
Pfizer Investigational Site Layton Utah 841041 —
Pfizer Investigational Site Salt Lake City Utah 84107 —
Pfizer Investigational Site South Jordan Utah 84095 —
Pfizer Investigational Site Virginia Beach Virginia 23454 —
Pfizer Investigational Site Virginia Beach Virginia 23455 —
Pfizer Investigational Site Seattle Washington 98104 —
Pfizer Investigational Site Seattle Washington 98122 —
Pfizer Investigational Site Seattle Washington 98166-2967 —
Pfizer Investigational Site Spokane Washington 99204 —
Pfizer Investigational Site Yakima Washington 98902 —
Pfizer Investigational Site Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00151489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00151489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →